Table 2.
Advantages | Disadvantages | |
---|---|---|
Orthotopic Liver Transplantation (OLT) | 88% patient survival Clinically defined |
Shortage of donors Post-surgery complications Life-long immunosuppressive treatment Organ rejection |
Artificial Liver (AL) Device | Detoxification ability Bridge patients to OLT |
Selective removal/detoxification of toxins Ineffective against encephalopathy Temporary support device |
Cell Transplantation | Surgical procedure safer and less invasive than OLT Partial correction of liver metabolic disorders |
Shortage of cells Transitory improvement of patients’ conditions |
Bio Artificial Liver (BAL) Device | Improved detoxification ability due to biological components Bridge patients to OLT |
Shortage of cells Clinical trials suspended or incomplete Complex set-up and scale-up |
Decellularized/Cellularized
Liver Scaffolds
(Pre-Clinical Development) |
Improvement of hepatic cells functions with respect to classic scaffold-based culture approaches Liver-like tissue bio-construction transplantable |
Shortage of cells Partial cell repopulation of the scaffolds Slow maturation of the construct Poor viability in pre-clinical studies |
Liver Biofabrication and Bioprinting
(Pre-Clinical Development) |
Easy scale-up of the 3D liver constructs Improvement of hepatic cell maturations with respect to 3D classic culture approaches |
Shortage of cells Slow maturation of the construct Contradictory published data on construct viability |